Skip to content

Ketamine research published in 2025

Page 24 of 39: studies 461 to 480 of 780, newest first. Back to the ketamine overview

Studies

Behavioral and psychological correlates of problematic smartphone use in street ketamine users.

BMC Psychology April 27, 2025 Chia-Heng Lin, Yang-Lin Lin, Chia-Hsiang Chan

While problematic smartphone use screening tools are widely used and increasingly evaluated in student populations, their applicability and clinical stability across diverse groups-particularly those with comorbid substance use-remain unclear. Moreover, the overlap between problematic smartphone use and internet gaming disorder has not been well established in clinical contexts. This study...

DOI: 10.1186/s40359-025-02778-x (opens in new tab) Full text (opens in new tab) Attention-deficit/hyperactivity disorder Behavioral addiction Internet gaming Problematic smartphone use +4

Molecular Mechanisms and Toxic Effects of Ketamine.

Fa yi xue za zhi April 25, 2025 Yu-Meng Zuo, Wei Han, Jian-Bo Zhang et al.

Ketamine is a dissociative anesthetic. It is clinically used as a surgical anesthetic or anesthetic inducer and has a certain degree of mental dependence. Its abuse can lead to nerve damage, adverse emotional reactions and other toxic side effects. The primary mechanism by which ketamine exerts its pharmacological effects is to block N-methyl-D-aspartate receptors (NMDAR). It also functions...

DOI: 10.12116/j.issn.1004-5619.2024.341002 (opens in new tab) Full text (opens in new tab) Ketamine Forensic pathology Forensic toxicology Molecular mechanism +1

Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program.

Journal of Psychopharmacology April 25, 2025 Jolien Ke Veraart, Sanne Y Smith-Apeldoorn, Annemarie van der Meij et al. 6 citations

Oral esketamine for patients with treatment-resistant depression (TRD) could offer certain advantages over other routes, such as intravenous or intranasal, but it has not been systematically studied in a real-world setting. Here we present results from a relatively large naturalistic study to evaluate the effectiveness, tolerability, and safety of oral esketamine in patients with TRD. One...

DOI: 10.1177/02698811251332831 (opens in new tab) Full text (opens in new tab) Treatment-resistant depression Oral esketamine Real-world effectiveness Mental health treatment +1

Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study.

Pharmaceuticals April 25, 2025 Jolien K E Veraart, Cornelis F Vos, Nieko C Punt et al. 2 citations

Background: Esketamine is a rapidly acting antidepressant with robust efficacy in treatment-resistant depression (TRD). Diminishing therapeutic effects and attenuated side effects have been reported after long-term use. This study aimed to investigate its long-term pharmacokinetics and factors that may contribute to reduced efficacy over time in patients with TRD by evaluating the potential...

Ficus patyphylla STEM BARK EXTRACT REVERSES KETAMINE-INDUCED SCHIZOPHRENIC–LIKE BEHAVIORS IN RATS VIA MODULATION OF CHOLINERGIC, NITRERGIC AND OXIDATIVE PATHWAYS

AFRICAN JOURNAL OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT April 23, 2025

Ketamine challenge is a suitable animal model for evaluating cognitive, positive and negative symptoms of schizophrenia, besides oxidative stress, cholinergic, dopaminergic, GABAergic and nitrergic dysfunctions observed in the disease. Effects of Ficus platyphylla (FP) methanol extract on behavioral alterations triggered by ketamine were investigated in forced swim, open field, and new object...

Cognitive flexibility of male rats is increased by augmented punishment in a reversal learning task but ketamine has no detectable long-term effects.

Psychopharmacology April 22, 2025 Anthony N Nist, Stephen J Walsh, Timothy A Shahan

The probabilistic reversal learning task (PRL) is sometimes used in the context of major depressive disorder (MDD) to assess impairments in cognitive flexibility and feedback sensitivity because behavior in the task is sensitive to pharmacological interventions. Because traditional antidepressants are limited in their effectiveness, new drugs are needed to combat MDD. Ketamine has recently been...

Upper Respiratory Infections and Respiratory Adverse Events and Interventions in Emergency Department Sedation of Children.

Annals of emergency medicine April 22, 2025 Daniel S Tsze, Nick Barrowman, Maala Bhatt 1 citation

Children with upper respiratory infections (URIs) have an increased risk of respiratory adverse events when undergoing operative anesthesia and in general populations of children receiving procedural sedation. It is unclear if children with URI undergoing emergency department (ED) sedation share the same increased risk. We aimed to determine if the presence of a URI in children undergoing ED...

DOI: 10.1016/j.annemergmed.2025.03.016 (opens in new tab) Full text (opens in new tab) Ketamine Adverse events Upper respiratory infection Pediatric sedation +4

Ketamine-Assisted Group Therapy for Work-Related Stress in First Responders and Frontline Health Care Workers

Psychedelic Medicine April 21, 2025 Luke Flynn, Mary Rondeau, Martin Krsak et al. 1 citation

Introduction: Ketamine is an evidenced-based treatment for depression, and it has shown promise in addressing many other mental health conditions related to work-related stress or burnout, such as anxiety and post-traumatic stress disorder. Ketamine-assisted psychotherapy (KAP) is part of an emerging model of psychedelic medicine that employs psychoactive agents to support the psychotherapeutic...

Tusi use among the New York City nightclub-attending population.

Addiction April 20, 2025 Joseph J Palamar, Nina Abukahok, Patricia Acosta et al. 7 citations

'Tusi', also known as 'tusibí' or 'pink cocaine', is a drug concoction which previously emerged in Latin America and Europe and has recently acquired popularity in the United States (US). Consumers are often unaware that Tusi contains a mixture of ketamine and other drugs, and the concoction can be confused with 2C/2C-B (ring-substituted phenethylamines/4-bromo-2,5-dimethoxyphenethylamine) or...

Biotransformation of ketamine in terminal in vivo experiments under chronic intermittent hypoxia conditions and the role of AhR.

Archives of Toxicology April 19, 2025 António B Pimpão, Luísa Teixeira-Santos, Nuno R Coelho et al.

We were pioneers in describing aryl hydrocarbon receptor (AhR) activation by chronic intermittent hypoxia (CIH) in a rat pre-clinical model. This model mimics hypertension (HTN) secondary to obstructive sleep apnea, enabling longitudinal investigation of hypertension development. Concerns about the influence of barbiturates on AhR-regulated enzymes led us to opt for ketamine/medetomidine...

DOI: 10.1007/s00204-025-04044-w (opens in new tab) Full text (opens in new tab) Aryl hydrocarbon receptor Hydroxynorketamine Norketamine glucuronide Obstructive sleep apnea +4

Ketamine-induced static and dynamic functional connectivity changes are modulated by opioid receptors and biological sex in rats.

Neuropsychopharmacology April 19, 2025 Valeria Grasso, Joseph Tennyson, Raag D. Airan et al. 5 citations

Subanesthetic ketamine is currently used as a rapid-acting treatment for varied neuropsychiatric disorders. However, the mechanistic underpinnings of its therapeutic action remain unclear, and emerging clinical and preclinical evidence highlights a potential involvement of the opioid system. We used pharmacological functional ultrasound imaging data acquired during and after ketamine...

DOI: 10.1038/s41386-025-02108-0 (opens in new tab) Full text (opens in new tab) Psychopharmacology Depression treatment Sex differences Brain connectivity

Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity.

Trials April 17, 2025 Arash Mansoori, Amir Bazrafshan, Jamshid Ahmadi et al. 4 citations

The concomitant presence of major depressive disorder (MDD) and opioid use disorder (OUD) poses a formidable clinical challenge, warranting effective interventions that address both psychiatric and addictive components. This study sought to compare the efficacy of adjunctive ketamine and buprenorphine in mitigating anxiety symptom severity and craving intensity in individuals with co-occurring...

Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus

Journal of Psychopharmacology April 17, 2025 Artur Pałasz, Marta Pukowiec, Katarzyna Bogus et al.

Objective: Psychedelics are able to trigger highly intense and profound alterations in self-consciousness, perception, affective, and cognitive processes. Indeed, recent studies show that ketamine and psilocybin could be used as fast-acting antidepressants. However, the molecular and neurochemical mechanisms of these psychedelics and their actions at the level of diverse brain structures...

The Influence of Childhood Trauma on the Real‐World Effectiveness of Ketamine in Adults With Treatment‐Resistant Depression

Acta Psychiatrica Scandinavica April 16, 2025 Danica E. Johnson, Nelson B Rodrigues, Rodrigo B. Mansur et al.

Childhood trauma is a well‐established risk factor for major depressive disorder (MDD) and is often associated with attenuated response to conventional antidepressant therapies. Ketamine has emerged as an effective treatment for treatment‐resistant depression (TRD), but the impact of childhood trauma on its effectiveness remains unclear. Herein, we aimed to determine whether childhood trauma...

Nursing care in ketamine infusions for pain control in adults: a scoping review protocol.

JBI evidence synthesis April 16, 2025 Laura Borges Lopes Garcia Leal, Jadson Nilo Pereira Santos, Valquíria Aparecida da Silva et al.

This scoping review will map the available evidence on nursing care provided to adults receiving ketamine infusion for pain management in hospitals and outpatient clinics. The use of intravenous ketamine infusions has increased in various contexts, particularly for pain management as part of a multimodal approach. Although ketamine is associated with a lower risk of hemodynamic disorders and...

DOI: 10.11124/JBIES-24-00358 (opens in new tab) Full text (opens in new tab) Intravenous ketamine Nursing practice Pain management Patient assessment +4

Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis

Frontiers in Psychiatry April 15, 2025 Hao-Yan Li, Wen-jing Xu, Ya-Mei Wang et al.

Background Postoperative depression (POD) represents a serious complication in surgical patients, exacerbating morbidity and mortality rates while imposing a substantial economic burden on healthcare systems. Despite its widespread clinical use, the role of esketamine, an NMDA receptor antagonist with rapid antidepressant effects, remains understudied in perioperative settings. Therefore, we...

The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects in Two Clinical Studies.

Biological Psychiatry April 15, 2025 Mary L Woody, Rebecca Rohac, Iya Cooper et al. 1 citation

Ketamine is known for its rapid antidepressant effect, but its impact on affective information processing (including attentional bias [AB], a putative cognitive mechanism of depression) remains largely unexplored. We leveraged a novel measurement of AB and sought to 1) establish adequate test-retest reliability and validity among participants with depression prior to ketamine treatment and 2)...

The Lysing of Catatonia With Intravenous Ketamine Prior to Definitive Treatment With Electroconvulsive Therapy.

The Journal of ECT April 15, 2025 Erich J Conrad, Zachary F Stielper, Isabelle V Mermilliod et al.

The presence of catatonia refractory to routine pharmacologic management is often subsequently managed by electroconvulsive therapy. However, legal obstacles that delay the initiation of electroconvulsive therapy in a timely fashion may be present. This may lead to prolonged risks associated with immobility and result in other procedures such as percutaneous endoscopic gastrostomy (PEG) tube...

DOI: 10.1097/YCT.0000000000001151 (opens in new tab) Full text (opens in new tab) #ketamine-therapy ketamine treatment Ketamine infusion #catatonia-treatment catatonic syndrome Catatonic state +3

The 50% effective dose of remimazolam combined with different doses of esketamine for painless gastroscopy.

Scientific Reports April 14, 2025 Li Zhao, Xuelei Zhou, Linlin Chen et al. 5 citations

Remimazolam is a novel benzodiazepine sedative that provides effective sedation, stable haemodynamics, and minimal adverse effects during intravenous general anaesthesia. The aim of this study was to determine the 50% effective dose (ED50) of remimazolam combined with different doses of esketamine for painless gastroscopy and to evaluate the efficacy and safety of this combination. This was a...

DOI: 10.1038/s41598-025-97649-1 (opens in new tab) Full text (opens in new tab) Esketamine Gastrointestinal endoscopy Median effective dose Painless gastroscopy +5

N1 cassette-lacking NMDA receptors mediate the antidepressant activity of ketamine

bioRxiv Preprint Server April 12, 2025 Alina T. He, Wenbo Zhang, Hongbin Li et al. preprint

Ketamine has emerged as a rapid-acting and robust antidepressant1,2. However, the mechanism of its antidepressant action remains enigmatic. The core issue that has yet to be resolved is whether NMDA receptors (NMDARs), which are subject to open channel blockade by ketamine3,4, mediate the antidepressant effect. NMDARs naturally undergo alternative splicing of the obligatory GluN1 subunit5,...